High proliferation by the MCL35 assay is associated with inferior outcomes in patients treated with intensive regimens – a correlative study from the Alliance 50403 trial.
- Citation:
- Hematol Oncol vol 35 (suppl S2) 152-2
- Meeting Instance:
- ICML 2017
- Year:
- 2017
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3168
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- Lymphoma
- Pharmas:
- Grants:
- U10CA180821, U10CA180882
- Corr. Author:
- Authors:
- David W. Scott Brandelyn Pitcher Yi Tian Liu Merrill Boyle Anja Mottok Jonathan Said Amy Chadburn Raymond Lai Sin-Ho Jung John P. Leonard Lawrence D. Kaplan Eric D. Hsi
- Networks:
- 11030, CA824, COLUMBUS, LAPS-MN026, NY018
- Study
- CALGB-50403
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: